Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

Professional Development

The future of magazines: Nine-and-a-half observations from the frontline

An open magazine with blank pages and abstract image panels rests on a desk beside a tablet.

The future of magazines: Nine-and-a-half observations from the frontline, with Gill Hudson, Editor, Reader’s Digest and former editor of Radio Times. This Reuters Institute for the Study of Journalism Professional Development event takes place on 9 March 2012 in the Seminar Room, Nuffield College.

Hosted with: Psychedelic Writers Guild